ArticleJournal of visualized surgery2025
Fluoroscopy-free Impella repositioning after coronary artery bypass grafting: case report of a novel echocardiographic-guided technique.
Article in Journal of visualized surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiogenic shock (CS) complicates 5-10% of myocardial infarctions and is a major cause of morbidity and mortality. Temporary mechanical circulatory support (MCS), such as the Impella CP device, has become crucial for stabilizing patients with severe left ventricular dysfunction. However, device positioning remains challenging, particularly when complications arise, such as the need for repositioning or replacement. This case report presents an innovative approach to fluoroscopy-free Impella repositioning using transesophageal echocardiography (TEE) guidance, which has not been previously documented in the context of coronary artery bypass grafting (CABG) and mitral valve surgery. Case Description: A 55-year-old male with severe left ventricular dysfunction and a history of diabetes and dyslipidemia was admitted with acute chest pain. Coronary angiography revealed severe three-vessel disease. After initial stabilization with an intra-aortic balloon pump (IABP), an Impella CP device was deployed for additional hemodynamic support. The patient then underwent CABG with five grafts and mitral valve repair via a median sternotomy. Before the CABG, the Impella device was temporarily positioned in the descending aorta to allow clamping of the ascending aorta during surgery. After the procedure, the Impella device was repositioned from the descending aorta to the left ventricle (LV) under TEE guidance. Manual pressure was applied externally by the surgeon to facilitate the pigtail catheter's passage through the valve. Once the device entered the LV, its final position was confirmed with TEE in both long-axis and short-axis views, ensuring optimal placement in the left ventricular cavity. Conclusions: This case demonstrates the feasibility and safety of performing Impella repositioning without fluoroscopy. By utilizing echocardiography for device guidance, the approach reduces the risk of vascular injury and eliminates the need for additional large-bore arterial access. This method represents a novel strategy for improving the management of patients with severe left ventricular dysfunction post-surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.